Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Anzueto, J. Hurts, H. Müllerova, N. Locantore, J. Wedzicha, J. Vestbo, ECLIPSE Investigators (SCO104960, NCT00292552) (San Antonio, RTP, United States Of America; London, Greenford, United Kingdom; Hvidovre, Denmark). Prevalence and characteristics of nonexacerbators in COPD gold stage 4. Results from the eclipse cohort study. Eur Respir J 2009; 34: Suppl. 53, 983

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of co-morbidities in Greek COPD patients in relation to the stage of the disease (COMPACT study) Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 Baseline characteristics of patients admitted for the first time for COPD exacerbation. The ²phenotype and course of COPD² (PAC-COPD) study Source: Annual Congress 2007 - Epidemiology of COPD Year: 2007 Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Sputum characteristics of stable COPD patients after a first admission for an exacerbation. The "phenotype and course of COPD" (PAC-COPD) study Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006 Incidence of COPD in a sample of patients with psychosis: preliminary data from a 10 years longitudinal study Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Four years follow-up of exacerbations in a cohort of COPD patients: 1 year interim results (EXACO study) Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Early detection of COPD: evidence from a population cohort study Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007 Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Exacerbations in a cohort of COPD patients: frequent exacerbators characteristics after 1-year follow-up (EXACO study – interim analysis) Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort. Source: International Congress 2017 – Markers of COPD progression Year: 2017 The characteristics of ACOS in a population based asthma cohort Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 Prevalence of severe asthma – results from a population-based study. Source: International Congress 2019 – Asthma and the world Year: 2019 GOLD classification of COPD and subsequent mortality: findings from a cohort study Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment Year: 2004 Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study Source: Annual Congress 2011 - COPD management Year: 2011 The association of comorbidity clusters with long-term survival and incidence of exacerbation in a COPD cohort. The HUNT Study, Norway. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 SGRQ-C distribution in the evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) cohort: Characteristics of COPD subjects with extreme score quintiles Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010 Latent class analyses used to study phenotypes in severe COPD with exacerbation. A pilot study Source: Annual Congress 2010 - Epidemiological data for smoking control Year: 2010 Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study. Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study) Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90 Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015